Therefore, repressing the connection between TRPM7 and MHC, along with impeding its phosphorylation, may present a promising therapeutic approach for diminishing the occurrence of breast cancer metastases (Saldías et al., 2021). The gene discussed is HLA-C; the disease is breast carcinoma.